At present, circumstantial evidence suggests that maternal/fetal ABO incompatibility decreases the risk of the sensitization to RhD, raising the possibility that preexisting ABO antibodies facilitate so-called antibody-mediated immunosuppression (AMIS) (105). The gene discussed is ABO; the disease is rheumatic heart disease.